National Genetics Institute; a LabCorp subsidiary Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
National Genetics Institute (NGI), a LabCorp subsidiary based in Los Angeles, California, operates in the biotechnology research space by delivering advanced genetics testing services for blood screening, medical testing, and clinical research. Its offerings include assays for HIV and the hepatitis A, B, and C viruses, along with other infectious agents, and NGI has developed high-throughput methods for pooled specimen nucleic acid testing, supporting efficient screening processes. The company serves customers in clinical laboratories and research settings that require validated genetic and infectious disease testing, addressing the need for sensitive, reliable diagnostic data. NGI is licensed as a clinical laboratory provider by state and federal authorities and participates in quality control programs, underscoring its regulatory compliance and focus on standards within the field. Based in Los Angeles, NGI operates within the biotechnology research industry and maintains active Biologics Licenses from the FDA for screening plasma for blood-borne infectious agents, reflecting its role in safety-critical testing contexts.